Advertisement

Topics

[Review] Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review

20:02 EDT 20 Jun 2017 | The Lancet

Most of the European Union (EU) and European Economic Area (EEA) is considered a region of very low hepatitis A virus (HAV) endemicity; however, geographical differences exist. We did a systematic review with the aim of describing seroprevalence and susceptibility in the general population or special groups in the EU and EEA. We searched databases and public health national institutes websites for HAV seroprevalence records published between Jan 1, 1975, and June 30, 2014, with no language restrictions.

Original Article: [Review] Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review

NEXT ARTICLE

More From BioPortfolio on "[Review] Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...